经心房途径经导管二尖瓣置换术治疗二尖瓣环钙化:技术描述与8例早期结果
该文系统描述了经心房途径使用球囊扩张式主动脉瓣膜行经导管二尖瓣置换术(TMVR)的逐步技术,并报告了8例严重二尖瓣环钙化患者的30天结局。技术成功率与30天手术成功率按MVARC标准均为100%,院内及30天死亡率为零,多数患者瓣周漏为无或微量。作者认为该技术可重复且早期结果良好,适用于严重瓣环钙化的二尖瓣病变。
要点
- 经心房TMVR使用球囊扩张式主动脉瓣膜,技术可重复,适用于严重二尖瓣环钙化。
- 8例患者MVARC技术成功率和30天手术成功率均为100%,零院内及30天死亡。
- 术后即刻瓣周漏6例无或微量、1例轻度。
核心结论
- 经心房途径TMVR技术可重复,在严重二尖瓣环钙化患者早期经验中结局良好。
- 结构化的植入技术对该领域发展至关重要。
研究设计与样本
- 单中心回顾性技术描述与病例系列,纳入8例接受经心房TMVR的患者。
- 5例有既往心脏手术史,平均STS评分为8%。
- 报告基线临床与超声特征及术后30天结局。
主要发现
- 按MVARC标准技术成功率为100%。
- 院内死亡和30天死亡率均为零。
- 按MVARC标准30天手术成功率为100%。
- 术后即刻瓣周漏:6例无或微量,1例轻度。
关键数值与推荐
- 技术成功按MVARC标准为100%。
- 30天手术成功按MVARC标准为100%。
- 平均STS评分为8%。
- 术后即刻瓣周漏无或微量6例、轻度1例。
临床怎么用
- 对严重二尖瓣环钙化高外科风险患者,可考虑经心房TMVR作为替代途径。
- 采用结构化逐步植入技术有助于应对瓣膜迁移、左室流出道梗阻和瓣周漏。
局限性
- 单中心、样本量仅8例的早期经验,结果需更大规模研究验证。
- 为技术描述性病例系列,非对照研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Mitral valve replacement in the setting of severe mitral annular calcification remains a surgical challenge. Transcatheter mitral valve replacement (TMVR) using an aortic balloon-expandable transcatheter heart valve is emerging as a potential treatment option for high surgical risk patients. Transseptal, transapical, or transatrial access is not always feasible, so an understanding of alternative implantation techniques is important. OBJECTIVES: The authors sought to present a step-by-step description of a contemporary transatrial TMVR technique using balloon-expandable aortic transcatheter heart valves. This procedure has evolved over time to address valve migration, left ventricular outflow tract obstruction, and paravalvular leak. The authors present a refined technique that has been associated with the most reproducible outcomes. METHODS: A step-by-step description of the TMVR technique and outcomes of 8 patients treated using this technique are described. Baseline patient clinical and echocardiographic characteristics and 30-day post-TMVR outcomes are presented. RESULTS: Eight patients underwent transatrial TMVR at a single institution. Five had previous cardiac surgery. Mean STS score was 8%. Technical success by MVARC (Mitral Valve Academic Research Consortium) criteria was 100%. There was zero in-hospital and 30-day mortality. Procedural success by MVARC criteria at 30 days was 100%. Paravalvular leak immediately post-implant was none or trace in 6 and mild in 1. CONCLUSIONS: The technique described is reproducible and was associated with favorable outcomes in this early experience. It represents a useful technique for the treatment of mitral valve disease in the setting of severe annular calcification. A structured and defined implantation technique is critical to investigators as this field evolves.
引用
- Russell HM, Guerrero ME, Salinger MH, et al. Open atrial transcatheter mitral valve replacement in patients with mitral annular calcification. J Thorac Cardiovasc Surg. 2018. PMID: 33198014. doi:10.1016/j.jtcvs.2018.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。